506
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Pediatric Guillain–Barré Syndrome in a Resource Limited Setting: Clinical Features, Diagnostic and Management Challenges, and Hospital Outcome

ORCID Icon, & ORCID Icon
Pages 107-115 | Received 14 Dec 2022, Accepted 07 Mar 2023, Published online: 22 Mar 2023

References

  • Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–727. doi:10.1016/S0140-6736(16)00339-1
  • Yuki N, Hartung H. Review article: Guillain–Barré syndrome. N Engl J Med. 2012;366:2294–2304. doi:10.1056/NEJMra1114525
  • Levison LS, Thomsen RW, Markvardsen LK, Christensen DH, Sindrup SH, Andersen H. Pediatric Guillain-Barré Syndrome in a 30-year nationwide cohort. Pediatr Neurol. 2020;107:57–63. doi:10.1016/j.pediatrneurol.2020.01.017
  • Papri N, Islam Z, Leonhard SE, Mohammad QD, Endtz HP, Jacobs BC. Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects. Nat Rev Neurol. 2021;17(5):285–296. doi:10.1038/s41582-021-00467-y
  • Hicks CW, Kay B, Worley SE, Moodley M. A clinical picture of Guillain-Barré Syndrome in children in the United States. J Child Neurol. 2010;25(12):1504–1510. doi:10.1177/0883073810370481
  • Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study. Neuropediatrics. 2007;38(1):10–17. doi:10.1055/s-2007-981686
  • Tang J, Dai Y, Li M, et al. Guillain-Barré syndrome in Chinese children: a retrospective analysis. Pediatr Neurol. 2011;45(4):233–237. doi:10.1016/j.pediatrneurol.2011.06.007
  • Van Den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469–482. doi:10.1038/nrneurol.2014.121
  • Wu X, Shen D, Li T, et al. Distinct clinical characteristics of pediatric guillain-Barré syndrome: a comparative study between children and adults in Northeast China. PLoS One. 2016;11(3):1–12.
  • Roodbol J, De Wit MCY, Walgaard C, De Hoog M, Catsman-Berrevoets CE, Jacobs BC. Recognizing Guillain-Barré syndrome in preschool children. Neurology. 2011;76(9):807–810. doi:10.1212/WNL.0b013e31820e7b62
  • Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain‐Barré syndrome. Ann Neurol. 1990;27(1S):S21–4. doi:10.1002/ana.410270707
  • Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599–612. doi:10.1016/j.vaccine.2010.06.003
  • Nepal G, Shrestha GS, Shing YK, Yadav JK, Coghlan MA, Ojha R. Low-cost alternatives for the management of Guillain-Barré syndrome in low- and middle-income countries. World Med Heal Policy. 2021;13(4):749–757. doi:10.1002/wmh3.474
  • Care N, Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC. Respiratory Dysfunction in Guillain-Barré Syndrome. Neurocrit Care. 2004;1:415–422. doi:10.1385/NCC:1:4:415
  • Ishaque T, Jacobs MC, Zhahiru I. High mortality from Guillain-Barré syndrome in Bangladesh. J Peripher Nerv Syst. 2017;22(2):121–126. doi:10.1111/jns.12215
  • Hosseininezhad M, Khatami SS, Saadat S, et al. Ten years evaluation of epidemiology- and mortality-related factors in adults and children with Guillain-Barré syndrome in the north of Iran. Neurol Sci. 2022;43(3):1929–1938. doi:10.1007/s10072-021-05562-y
  • Berg B, Bunschoten C, Doorn PA. Mortality in Guillain-Barré syndrome. Neurology. 2013;80:6–11.
  • Kalra V, Sankhyan N, Sharma S, Gulati S, Choudhry R, Dhawan B. Outcome in childhood Guillain-Barré syndrome. Indian J Pediatr. 2009;76(8):795–799. doi:10.1007/s12098-009-0125-y
  • Estrade S, Guiomard C, Fabry V, et al. Prognostic factors for the sequelae and severity of Guillain-Barré syndrome in children. Muscle Nerve. 2019;60(6):716–723. doi:10.1002/mus.26706
  • Lee JH, Sung IY, Rew IS. Clinical presentation and prognosis of childhood Guillain-Barré syndrome. J Paediatr Child Health. 2008;44(7–8):449–454. doi:10.1111/j.1440-1754.2008.01325.x
  • Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled Trial of Prednisolone in Acute Polyneuropathy. Lancet. 1978;312(8093):750–753. doi:10.1016/S0140-6736(78)92644-2
  • Korinthenberg R, Trollmann R, Felderhoff-Müser U, et al. Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: an evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020;25:5–16. doi:10.1016/j.ejpn.2020.01.003
  • Doets AY, Verboon C, van den Berg B, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866–2877. doi:10.1093/brain/awy232
  • Sipilä JOT, Soilu-Hänninen M, Ruuskanen JO, Rautava P, Kytö V. Epidemiology of Guillain-Barré syndrome in Finland 2004–2014. J Peripher Nerv Syst. 2017;22(4):440–445. doi:10.1111/jns.12239
  • Mathew T, Srinivas M, Nadig R, Arumugam R, Sarma GRK. Seasonal and monthly trends in the occurrence of Guillain-Barre syndrome over a 5-year period: a tertiary care hospital-based study from South India. Ann Indian Acad Neurol. 2014;17(2):239–241. doi:10.4103/0972-2327.132662
  • Woyessa AB, Mengesha M, Belay D, et al. Epidemiology of influenza in Ethiopia: findings from influenza sentinel surveillance and respiratory infection outbreak investigations, 2009–2015. BMC Infect Dis. 2018;18(1):1–10. doi:10.1186/s12879-018-3365-5
  • Bacha T, Gezahegn W, Amare A. The clinical presentation, epidemiology, and short-term outcome of guillain-barré syndrome in tikuranbessa hospital: a 6-year retrospective study. Ethiop Med J. 2018;56(2):141–146.
  • Kim SH, Samadov F, Mukhamedov A, et al. Clinical characteristics and prognostic factors of children with Guillain-Barré syndrome. Ann Child Neurol. 2019;27(4):113–119. doi:10.26815/acn.2019.00143
  • Howlett WP, Vedeler CA, Nyland H, Aarli JA. Guillain-Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol Scand. 1996;93(1):44–49. doi:10.1111/j.1600-0404.1996.tb00169.x
  • Khan RSY, Ali S, Irfan S, Naseem F. Frequency of cranial nerve involvement in patients with syndrome. Ann Pak Inst Med Sci. 2015;11(3):115–118.
  • Incecik F, Hergüner MO, Altunbasak S. Guillain-Barré syndrome in children. Neurol Sci. 2011;32(3):381–385. doi:10.1007/s10072-010-0434-y
  • Leonhard SE, Mandarakas MR, Gondim FAA, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol. 2019;15(11):671–683. doi:10.1038/s41582-019-0250-9
  • Solana-Rojas Á, García-Melo LM, Reyes-Varela MD, et al. Clinical severity and associated complications in pediatric patients with Guillain-Barré syndrome. Rev Mex Neurocienc. 2020;21(1):15–26.
  • Ryan MM. Guillain–Barr ´e syndrome in childhood. J Paediatr Child Health. 2005;41:237–241. doi:10.1111/j.1440-1754.2005.00602.x
  • Hasan I, Papri N, Hayat S, et al. Clinical and serological prognostic factors in childhood Guillain-Barré syndrome: a prospective cohort study in Bangladesh. J Peripher Nerv Syst. 2021;26(1):83–89. doi:10.1111/jns.12434
  • Sedano MJ, Orizaola P, Gallardo E, et al. A unicenter, prospective study of Guillain-Barré syndrome in Spain. Acta Neurol Scand. 2019;139(6):546–554. doi:10.1111/ane.13092